Showing results (71-80 of 170) with videos related to
Sort By:
Pageof 17
Journal of Neurology|August 22, 2025
AI-Based EMG Reporting: A Randomized Controlled TrialAlon Gorenshtein, Yana Weisblat, Mohamed Khateb, et al.Journal of Clinical Medicine|September 13, 2025
AI Based Clinical Decision-Making Tool for Neurologists in the Emergency DepartmentAlon Gorenshtein, Shiri Fistel, Moran Sorka, et al.Journal of the Neurological Sciences|November 4, 2011
Implementing clinical trials on an international platform: challenges and perspectivesGreg Minisman, Minal Bhanushali, Robin Conwit, et al.Rheumatology (Oxford, England)|September 17, 2021
Survival and associated comorbidities in inclusion body myositisElie Naddaf, Shahar Shelly, Jay Mandrekar, et al.Brain Communications|December 11, 2020
Immune checkpoint inhibitor-associated myopathy: a clinicoseropathologically distinct myopathyShahar Shelly, James D Triplett, Marcus V Pinto, et al.Journal of Clinical Neuromuscular Disease|November 21, 2022
Nitrofurantoin and Minocycline-Associated Vasculitic Neuropathy: Case Reports and Literature ReviewMohammad Aladawi, Shahar Shelly, P James B Dyck, et al.Journal of the Neurological Sciences|September 26, 2021
IgG regulation through FcRn blocking: A novel mechanism for the treatment of myasthenia gravisGil I Wolfe, E Sally Ward, Hans de Haard, et al.Plos One|October 10, 2023
Serum metabolomics of treatment response in myasthenia gravisPatricia Sikorski, Yaoxiang Li, Mehar Cheema, et al.Annals of the New York Academy of Sciences|January 3, 2013
Biomarker development for myasthenia gravisHenry J Kaminski, Linda L Kusner, Gil I Wolfe, et al.Archives of Neurology|January 21, 2004
Transverse myelitis in systemic sclerosisAmir M Torabi, Rahul K Patel, Gil I Wolfe, et al.Pageof 17